Value of PCA3 to Predict Biopsy Outcome and Its Potential Role in Selecting Patients for Multiparametric MRI

Value of PCA3 to Predict Biopsy Outcome and Its Potential Role in Selecting Patients for Multiparametric MRI

PCA3 (prostate cancer gene 3) and multiparametric 3 tesla MRI are new promising diagnostic tools in the detection of PCa. Our aim was to study the clinical value of the Progensa PCA3-test: its predictive value for biopsy outcome, Gleason score and MRI outcome. We evaluated, retrospectively, 591 pati...

Full description

Bibliographic Details
Main Authors: Peter F. A. Mulders, Jack A. Schalken, Jelle O. Barentsz, J. P. Michiel Sedelaar, Jurgen J. Futterer, Inge M. van Oort, Elisabeth A. Wierenga, Gisele H. J. M. Leyten
Format: Article
Language:English
Published: MDPI AG 2013-05-01
Series:International Journal of Molecular Sciences
Subjects:
prostate cancer
PCA3
MRI
Online Access:http://www.mdpi.com/1422-0067/14/6/11347

Internet

http://www.mdpi.com/1422-0067/14/6/11347

Similar Items